NCOA4 and prostate adenocarcinoma: Second, the detection of MSMB, NCOA4 and MSMB-NCOA4 fusion transcripts was assessed using RNA-seq in two cohorts; one containing 12 BPH, 28 hormone-naïve PC, and 13 CRPC samples [32], as well as a second TCGA-cohort consisting of 301 prostate adenocarcinoma tumors.